当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析

甘李药业

(603087)

  

流通市值:412.70亿  总市值:442.05亿
流通股本:5.58亿   总股本:5.98亿

甘李药业(603087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润6.04亿元,每股收益1.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1096523.07万元,未分配利润676487.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1187779.55万元,负债91256.48万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,066,795,642.77984,867,402.613,045,347,805.112,245,006,087.12
营业总成本1,515,608,273.35739,374,819.172,663,266,844.191,921,772,067.24
其他经营收益
营业利润631,605,004.11299,042,200.26631,540,152.08562,258,052.99
利润总额691,021,014.97360,390,884.31630,385,148.09563,604,698.92
净利润603,680,572.48311,918,723.02614,663,800.7507,265,199.52
每股收益
其他综合收益-21,049.12338,986.22219,526.81-865,256.02
综合收益总额603,659,523.36312,257,709.24614,883,327.51506,399,943.5
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,966,168,927.343,900,272,940.753,790,858,209.056,488,421,495.55
非流动资产:
非流动资产合计7,911,626,582.458,384,161,878.048,252,058,182.835,733,199,169.99
资产总计11,877,795,509.7912,284,434,818.7912,042,916,391.8812,221,620,665.54
流动负债:
流动负债合计735,070,490.35793,214,596.86801,131,734.24806,674,618.97
非流动负债:
非流动负债合计177,494,307.38179,096,772.33187,313,995.46208,081,711.71
负债合计912,564,797.73972,311,369.19988,445,729.71,014,756,330.68
所有者权益(或股东权益):
归属于母公司股东权益合计10,965,230,712.0611,312,123,449.611,054,470,662.1811,206,864,334.86
股东权益合计10,965,230,712.0611,312,123,449.611,054,470,662.1811,206,864,334.86
负债和股东权益合计11,877,795,509.7912,284,434,818.7912,042,916,391.8812,221,620,665.54
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,959,456,149.261,016,722,117.213,388,272,777.652,482,539,982.35
经营活动现金流出小计1,710,905,907.17857,975,850.442,850,963,054.352,017,199,688.5
经营活动产生的现金流量净额248,550,242.09158,746,266.77537,309,723.3465,340,293.85
投资活动产生的现金流量:
投资活动现金流入小计3,156,092,918.682,058,063,660.248,857,807,746.377,094,140,190.14
投资活动现金流出小计2,626,039,316.12,030,819,263.169,119,836,143.87,574,018,744.4
投资活动产生的现金流量净额530,053,602.5827,244,397.08-262,028,397.43-479,878,554.26
筹资活动产生的现金流量:
筹资活动现金流入小计--139,321,600139,321,600
筹资活动现金流出小计733,344,416.0775,214,479.7440,035,383137,407,531.31
筹资活动产生的现金流量净额-733,344,416.07-75,214,479.7-300,713,7831,914,068.69
汇率变动对现金及现金等价物的影响3,302,350.071,466,877.94-951,386.7-1,572,201.8
现金及现金等价物净增加额48,561,778.67112,243,062.09-26,383,843.83-14,196,393.52
期末现金及现金等价物余额308,616,915.43372,298,198.85260,055,136.76272,242,587.07
补充资料:
现金及现金等价物的净增加额48,561,778.67--26,383,843.83-
最新报告期:2025-09-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋李啸岩,谭紫媚1.922.473.072025-09-11
中信证券陈竹,韩世通1.912.413.022025-08-20
兴业证券孙媛媛,黄翰漾1.932.412.872025-08-15
华安证券谭国超1.852.372.972025-08-13
平安证券叶寅,张梦鸽,韩盟盟2.012.553.052025-08-12
TOP↑